Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Ayano M, Ueda N, Mishima K, Ota SI, Kushimoto K, Tanaka A, Kawano S, Nishimura N, Kashiwado Y, Doi G, Nakayama T, Fukumoto R, Tsuru T, Suzaki M, Akahoshi M, Maekawa M, Omoto A, Tada H, Akashi K, Horiuchi T, Niiro H. Ayano M, et al. Among authors: kashiwado y. Mod Rheumatol. 2024 Dec 25;35(1):102-109. doi: 10.1093/mr/roae058. Mod Rheumatol. 2024. PMID: 39096517
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.
Kashiwado Y, Kimoto Y, Ohshima S, Sawabe T, Irino K, Nakano S, Hiura J, Yonekawa A, Wang Q, Doi G, Ayano M, Mitoma H, Ono N, Arinobu Y, Niiro H, Hotta T, Kang D, Shimono N, Akashi K, Takeuchi T, Horiuchi T. Kashiwado Y, et al. Rheumatology (Oxford). 2024 Mar 1;63(3):725-733. doi: 10.1093/rheumatology/kead275. Rheumatology (Oxford). 2024. PMID: 37289506
Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study.
Kashiwado Y, Kiyohara C, Kimoto Y, Nagano S, Sawabe T, Oryoji K, Mizuki S, Nishizaka H, Yoshizawa S, Yoshizawa S, Tsuru T, Inoue Y, Ueda N, Ota SI, Suenaga Y, Miyamura T, Tada Y, Niiro H, Akashi K, Horiuchi T. Kashiwado Y, et al. Arthritis Res Ther. 2022 Jun 1;24(1):131. doi: 10.1186/s13075-022-02820-y. Arthritis Res Ther. 2022. PMID: 35650638 Free PMC article.
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study.
Kashiwado Y, Kimoto Y, Sawabe T, Irino K, Nakano S, Hiura J, Wang Q, Kawano S, Ayano M, Mitoma H, Ono N, Arinobu Y, Niiro H, Hotta T, Kang D, Akashi K, Ohshima S, Takeuchi T, Horiuchi T. Kashiwado Y, et al. Mod Rheumatol. 2023 Mar 2;33(2):367-372. doi: 10.1093/mr/roac030. Mod Rheumatol. 2023. PMID: 35411376 Free PMC article.
Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
Saiki C, Kashiwado Y, Yokoyama T, Ayano M, Imabayashi K, Kawano S, Higashioka K, Kimoto Y, Fukata M, Mitoma H, Ono N, Arinobu Y, Akashi K, Horiuchi T, Niiro H. Saiki C, et al. Among authors: kashiwado y. Mod Rheumatol Case Rep. 2022 Jun 24;6(2):183-188. doi: 10.1093/mrcr/rxac009. Mod Rheumatol Case Rep. 2022. PMID: 35134204
Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
Otsuka Y, Kiyohara C, Kashiwado Y, Sawabe T, Nagano S, Kimoto Y, Ayano M, Mitoma H, Akahoshi M, Arinobu Y, Niiro H, Akashi K, Horiuchi T. Otsuka Y, et al. Among authors: kashiwado y. PLoS One. 2018 Apr 25;13(4):e0196368. doi: 10.1371/journal.pone.0196368. eCollection 2018. PLoS One. 2018. PMID: 29694426 Free PMC article.
12 results